Literature DB >> 57820

Axonal transport in serotonin neurons of the midbrain raphe.

A E Halaris, B E Jones, R Y Moore.   

Abstract

The projections of serotonin-containing neurons of the midbrain raphe nuclei (nucleus raphe dorsalis, nucleus centralis superior) are studied by analysis of axonal transport of labeled amino acids. These results are correlated with regional alterations of serotonin content following midbrain raphe lesions which produce significant serotonin depletion in nearly all regions of the central nervous system. Twenty-four hours following injection of 100 muCi [3H]proline, raphe neurons have taken up labeled material and transported it, presumably as protein, to telencephalon, diencephalon, brain stem, the cerebellum and the spinal cord. This transport appears to take place predominantly in serotonin neurons. After injection of 100 muCi [3H]5-HTP into nucleus raphe dorsalis or nucleus centralis superior, the pattern of regional distribution of transported material is very similar to that obtained with tritiated proline. Selective lesions of serotonin terminals with 5.6-DHT result in greatly diminished axonal transport of proteins to all telencephalic, diencephalic and mesencephalic areas as well as to cerebellum, pons-medulla and spinal cord. Unilateral destruction of the medial forebrain bundle results in significant reduction in axonal transport of labeled material to ipsilateral telencehalon and thalamus. These results provide further support for the view that serotonin neurons of the midbrain raphe nuclei project widely throughout the neuraxis to telencephalon, diencephalon, brain stem, cerebellum and spinal cord.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 57820     DOI: 10.1016/0006-8993(76)90144-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  Serotonin-specific lesions of the dorsal raphe disrupt maternal aggression and caregiving in postpartum rats.

Authors:  M Allie Holschbach; Erika M Vitale; Joseph S Lonstein
Journal:  Behav Brain Res       Date:  2018-04-10       Impact factor: 3.332

2.  GAP-43 is critical for normal development of the serotonergic innervation in forebrain.

Authors:  Stacy L Donovan; Laura A Mamounas; Anne M Andrews; Mary E Blue; James S McCasland
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

3.  Experimental studies on 3,4-methylenedioxymethamphetamine (MDA, "ecstasy") and its potential to damage brain serotonin neurons.

Authors:  G A Ricaurte; U D McCann
Journal:  Neurotox Res       Date:  2001-01       Impact factor: 3.911

4.  Plasticity in singing effort and its relationship with monoamine metabolism in the songbird telencephalon.

Authors:  Katrina G Salvante; Danielle M Racke; C Ryan Campbell; Keith W Sockman
Journal:  Dev Neurobiol       Date:  2010-01       Impact factor: 3.964

5.  Voltammetric detection of 5-hydroxytryptamine release in the rat brain.

Authors:  Parastoo Hashemi; Elyse C Dankoski; Jelena Petrovic; Richard B Keithley; R M Wightman
Journal:  Anal Chem       Date:  2009-11-15       Impact factor: 6.986

6.  Selective anterograde tracing of nonserotonergic projections from dorsal raphe nucleus to the basal forebrain and extended amygdala.

Authors:  Adam L Halberstadt; Carey D Balaban
Journal:  J Chem Neuroanat       Date:  2008-03-08       Impact factor: 3.052

7.  Selective anterograde tracing of the individual serotonergic and nonserotonergic components of the dorsal raphe nucleus projection to the vestibular nuclei.

Authors:  A L Halberstadt; C D Balaban
Journal:  Neuroscience       Date:  2007-05-15       Impact factor: 3.590

8.  Detection of a High-Turnover Serotonin Circuit in the Mouse Brain Using Mass Spectrometry Imaging.

Authors:  Eiji Sugiyama; Matteo M Guerrini; Kurara Honda; Yuko Hattori; Manabu Abe; Patrik Källback; Per E Andrén; Kenji F Tanaka; Mitsutoshi Setou; Sidonia Fagarasan; Makoto Suematsu; Yuki Sugiura
Journal:  iScience       Date:  2019-09-27
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.